TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive US Could Lose Leadership In Research If NIH Budget Is Cut, ASCO President Says June 2, 1995
TCL Archive Shortfall In Centers Budget Threatens Grants Of Half Of The 17 Competing For Renewal In 1980 October 12, 1979
